RA can inhibit the expression of Fyn in HepG2 hepatoma cells, as well as the proliferation, migration, and invasion of hepatoma cells, and the expression of matrix metalloproteinase-2 (MMP-2) and matrix metalloproteinase-9 (MMP-9) in a dose-dependent manner. This evidence concerns the gene FYN and hepatocellular carcinoma.